tm logo
SATIO
Live/Pending
SECOND EXTENSION - GRANTED

granted

on 18 Sep 2024

Last Applicant/ Owned by

27 Drydock Ave., 3rd Floor

Boston

MA

02210

Serial Number

97512123 filed on 20th Jul 2022

Registration Number

N/A

Correspondent Address

Joshua S. Jarvis, Esq.

Joshua S. Jarvis, Esq. FOLEY HOAG LLP

BOSTON, MA 02210

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SATIO

Medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia Read More

Classification Information


Class [010]
Medical Instrument Products


Medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic apparatus for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; genetic testing apparatus for medical purposes; dermal patches for delivery of pharmaceuticals and vaccines, sold empty; medical devices for obtaining body fluid samples; medical devices for testing body fluid samples; dermal patches for testing DNA and RNA samples; dermal patches for testing for infectious diseases and non-infectious diseases, namely, hepatic diseases, , immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; dermal patches for testing for genetic testing; dermal patches for obtaining body fluid samples; dermal patches for testing body fluid samples


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Vaccines, namely, dermal patches featuring vaccines; pharmaceutical preparations for the prevention and treatment of infectious diseases and non-infectious diseases, namely, dermal patches featuring pharmaceutical preparations for the prevention and treatment of hepatic diseases, immune system diseases, renal diseases, metabolic diseases, endocrine diseases, thyroid diseases, diabetes, pancreatic diseases, cystic fibrosis, phenylketonuria, blood diseases, sickle cell disease, sickle cell anemia, galactosemia, and glucose-6-phosphate dehydrogenase (G6PD) deficiency; medical diagnostic reagents and assays for testing of body fluids, namely, dermal patches featuring medical diagnostics or assays for testing of body fluids; reagents for use in medical genetic testing, namely, dermal patches featuring reagents for use in medical genetic testing


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97512123

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 38298.00003

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Sep 2024SOU EXTENSION 2 GRANTED
18th Sep 2024SOU EXTENSION 2 FILED
18th Sep 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18th Sep 2024SOU TEAS EXTENSION RECEIVED
27th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
26th Apr 2024SOU EXTENSION 1 GRANTED
26th Apr 2024SOU TEAS EXTENSION RECEIVED
26th Apr 2024SOU EXTENSION 1 FILED
30th Nov 2023CORRECTED NOA E-MAILED
29th Nov 2023NOTICE OF ALLOWANCE CORRECTION ENTERED